XML 64 R32.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions (Tables)
 12 Months Ended
Dec. 31, 2012
Business Combinations [Abstract]  
Schedule of Purchase Price Allocation [Table Text Block]
The following table summarizes the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for all acquisitions consummated during 2012, 2011 and 2010 ($ in millions):
 
Total
2012
 
2011
 
2010
Trade accounts receivable
$
105.4

 
$
859.5

 
$
178.7

Inventories
97.0

 
812.4

 
171.2

Property, plant and equipment
87.5

 
1,042.1

 
84.8

Goodwill
1,015.7

 
4,164.7

 
1,157.8

Other intangible assets, primarily trade names, customer relationships and patents
768.3

 
2,772.4

 
870.9

In-process research and development
61.5

 
143.0

 
26.5

Trade accounts payable
(50.8
)
 
(278.2
)
 
(59.6
)
Other assets and liabilities, net
(287.7
)
 
(1,662.9
)
 
(238.4
)
Assumed debt
—

 
(1,640.4
)
 
(0.9
)
Non-controlling interest acquired
(0.1
)
 
(1.8
)
 
(61.3
)
Net cash consideration
$
1,796.8

 
$
6,210.8

 
$
2,129.7
Fair Values Of The Assets Acquired And Liabilities Assumed
The following tables summarize the estimated fair values of the assets acquired and liabilities assumed at the date of acquisition for the individually significant acquisitions in 2011 and 2010 discussed above, and all of the other 2011 and 2010 acquisitions as a group ($ in millions):

2011 Acquisitions
 
 
 
 
 
 
Beckman Coulter
 
Others
 
Total
Trade accounts receivable
$
783.3

 
$
76.2

 
$
859.5

Inventories
774.0

 
38.4

 
812.4

Property, plant and equipment
1,036.2

 
5.9

 
1,042.1

Goodwill
3,745.8

 
418.9

 
4,164.7

Other intangible assets, primarily customer relationships, trade names and patents
2,518.0

 
254.4

 
2,772.4

In-process research and development
143.0

 
—

 
143.0

Trade accounts payable
(257.3
)
 
(20.9
)
 
(278.2
)
Other assets and liabilities, net
(1,561.0
)
 
(101.9
)
 
(1,662.9
)
Assumed debt
(1,640.4
)
 
—

 
(1,640.4
)
Attributable to non-controlling interest
—

 
(1.8
)
 
(1.8
)
Net cash consideration
$
5,541.6

 
$
669.2

 
$
6,210.8





2010 Acquisitions
 
 
 
 
 
 
AB Sciex & Molecular Devices
 
Others
 
Total
Trade accounts receivable
$
102.7

 
$
76.0

 
$
178.7

Inventories
104.3

 
66.9

 
171.2

Property, plant and equipment
54.5

 
30.3

 
84.8

Goodwill
496.9

 
660.9

 
1,157.8

Other intangible assets, primarily customer relationships, trade names and patents
342.0

 
528.9

 
870.9

In-process research and development
7.4

 
19.1

 
26.5

Trade accounts payable
(37.9
)
 
(21.7
)
 
(59.6
)
Other assets and liabilities, net
(30.7
)
 
(207.7
)
 
(238.4
)
Assumed debt
(0.9
)
 
—

 
(0.9
)
Attributable to non-controlling interest
—

 
(61.3
)
 
(61.3
)
Net cash consideration
$
1,038.3

 
$
1,091.4

 
$
2,129.7
Results Of Operations If Acquisition Was Consummated
The pro forma information is presented for informational purposes only and is not necessarily indicative of the results of operations that actually would have been achieved had the acquisitions been consummated as of that time ($ in millions except per share amounts):
 
 
2012
 
2011
Sales
$
18,623.8

 
$
18,635.6

Net earnings from continuing operations
$
2,304.8

 
$
2,038.9

Diluted net earnings per share from continuing operations
$
3.24

 
$
2.88